Medication info
Terbinafine Tablets (Terbinafine Hydrochloride)

Terbinafine Tablets (Terbinafine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Terbinafine Hydrochloride›140.625mg / 1 tablet
Manufacturer / importer
Genewon Science Co., Ltd.
Appearance
White round tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200404722 · Notified 2004.01.26 · Insurance code 671701540

Summary

Main use
Treatment of onychomycosis and cutaneous fungal infections (such as tinea pedis and tinea corporis), and tinea capitis
Who takes it
Adults · Children
Adult dose
Administer terbinafine at 125 mg per dose twice daily or 250 mg per dose once daily. The duration of administration according to the condition is as follows. 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Administration is usually for 6 weeks~3 months. For infection of the fingernails or relatively small toenails, or in younger patients, the treatment period may be shortened to 3 months or less. For toenail infections, 3 months of treatment is usually sufficient, but some patients may require 6 months or longer. The treatment period may be longer in patients with slow nail growth. Reduce the daily dose by 1/2 in patients with creatinine clearance less than 50 mL per minute.
Child dose
Administer to children 2 years and older. Administration is not recommended for children under 2 years of age because there is no experience with use in this age group. Tinea capitis: 4 weeks Tinea capitis occurs mainly in children. To prevent recurrence of infection, treatment should be given regularly for the appropriate prescribed duration. Body weight less than 20 kg (under 5 years): Administer 62.5 mg per dose once daily. Because experience with use is limited, the decision to administer should be based on consideration of the benefits and risks of treatment. Body weight 20~40 kg (5~12 years): Administer 125 mg per dose once daily. Body weight over 40 kg (over 12 years): Administer 250 mg per dose once daily.

Ingredients

Manufacturer
Genewon Science Co., Ltd.

Efficacy & effects

Treatment of onychomycosis and cutaneous fungal infections (such as tinea pedis and tinea corporis), and tinea capitis

  • Dermatophyte infections
  • tinea pedis
  • tinea corporis
  • tinea cruris
  • onychomycosis
  • tinea capitis
View approved original text

This medication is used to treat dermatophyte infections such as tinea pedis, tinea corporis, and tinea cruris in adults, as well as onychomycosis. It is also effective for treating tinea capitis in children. It helps improve fungal infections that occur on the skin and nails.

How to take

Adult dose

Administer terbinafine at 125 mg per dose twice daily or 250 mg per dose once daily. The duration of administration according to the condition is as follows. 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Administration is usually for 6 weeks~3 months. For infection of the fingernails or relatively small toenails, or in younger patients, the treatment period may be shortened to 3 months or less. For toenail infections, 3 months of treatment is usually sufficient, but some patients may require 6 months or longer. The treatment period may be longer in patients with slow nail growth. Reduce the daily dose by 1/2 in patients with creatinine clearance less than 50 mL per minute.

Child dose

Administer to children 2 years and older. Administration is not recommended for children under 2 years of age because there is no experience with use in this age group. Tinea capitis: 4 weeks Tinea capitis occurs mainly in children. To prevent recurrence of infection, treatment should be given regularly for the appropriate prescribed duration. Body weight less than 20 kg (under 5 years): Administer 62.5 mg per dose once daily. Because experience with use is limited, the decision to administer should be based on consideration of the benefits and risks of treatment. Body weight 20~40 kg (5~12 years): Administer 125 mg per dose once daily. Body weight over 40 kg (over 12 years): Administer 250 mg per dose once daily.

Precautions

This medication is not recommended for patients with chronic liver disease or active liver disease. It is essential to confirm the presence of liver disease before administration, and regular liver function tests should be performed; if liver damage is suspected, discontinue use immediately. This medication should not be administered to patients with blood disorders or severe renal failure, infants under 2 years of age, nursing mothers, etc. In elderly patients, those with impaired renal function, and children weighing less than 20 kg, it should be administered with caution. If serious side effects such as skin rashes occur, use should be discontinued immediately. This medication may cause a variety of side effects, including hepatotoxicity, skin reactions, hematologic abnormalities, musculoskeletal pain, etc., so if any symptoms occur, contact your healthcare provider immediately. Patients should be cautious while driving or operating machinery as dizziness may occur. There may be interactions with other medications, so if you are taking other medications, you must inform your healthcare provider, especially if the drugs affect liver metabolism, as dosage adjustments may be necessary. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of using this medication, and nursing mothers should discontinue breastfeeding while on this medication. In case of overdose, symptoms may include headache, nausea, abdominal pain, and dizziness; appropriate medical treatment should be sought immediately. This medication should be kept out of reach of children and stored at room temperature away from direct sunlight.

Side effects

Liver and biliary tract failure, hepatitis, bile duct obstruction, jaundice, rash, skin itching, fever, nausea, vomiting, decreased appetite, lethargy, increased γ-GTP, elevated AST/ALT, increased LDH, elevated ALP, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, pharyngitis, fever, lymphadenopathy, purpura, petechiae, leukopenia, anemia, rash, itching, photosensitivity reaction, mucocutaneous syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rash, exfoliative dermatitis, blistering dermatitis, psoriasis-like rash, exacerbation of psoriasis, hair loss, musculoskeletal reaction, arthralgia, myalgia, weakness, elevated CPK, increased myoglobin, hypotension, respiratory distress, chest tightness, urticaria, erythema, facial edema, lymphangiectasia, abdominal distention, decreased appetite, dyspepsia, mild abdominal pain, diarrhea, gastric discomfort, thirst, vomiting, glossitis, depression, anxiety, headache, loss of taste, taste disorder, dizziness, drowsiness, sensory disturbance, sensory reduction, decreased attention, insomnia, increased BUN, polyuria, visual impairment, tinnitus, anaphylactic reaction, angioedema, systemic lupus erythematosus, elevated total cholesterol in the blood, increased triglyceride levels, lethargy, tongue discoloration, palpitations, edema, menstrual irregularities, paralysis, systemic disorders, fever, fatigue, weight loss, anaphylactic reaction, serum sickness-like reaction, blurred vision, diminished vision, hearing loss, auditory impairment, vasculitis, permanent loss of smell, hyposmia, eosinophilia, drug rash, pancreatitis, rhabdomyolysis, influenza-like illness, increased blood creatine phosphokinase, headache, nausea, upper abdominal pain, dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

White round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.